Tokyo, Japan

Keita Saku


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keita Saku: Innovator in Myocardial Infarction Treatment

Introduction

Keita Saku is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the treatment of myocardial infarction. His innovative approach combines advanced stimulation techniques with biological monitoring to enhance patient care.

Latest Patents

Keita Saku holds a patent for a "Control apparatus for treating myocardial infarction and control method for treating myocardial infarction." This invention features a stimulation control unit that outputs a stimulation signal to an electrode inserted near the vagus nerve. The device aims to reduce myocardial workload by stimulating the vagus nerve, thereby improving the patient's condition. The system includes a detecting unit for biological information, a setting unit for threshold information, and a determining unit to assess whether the patient's biological data falls within a normal range. The stimulation control unit adjusts the intensity of the stimulation signal to maintain these values within the desired range, ensuring effective treatment.

Career Highlights

Throughout his career, Keita Saku has worked with various companies, including Neuroceuticals, Inc. and Neuroceuticals Ivns Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical technology.

Collaborations

Keita has collaborated with notable professionals in his field, including Kenji Sunagawa and Shinya Miike. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Keita Saku is a pioneering inventor whose work in myocardial infarction treatment showcases the potential of innovative medical technologies. His contributions are vital in improving patient outcomes and advancing the field of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…